Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

52 results about "Poly ethylene glycol diacrylate" patented technology

Ethylene glycol diacrylate (EGDA) is a crosslinking homobifunctional monomer. PEG-based cross-linked polymeric materials (hydrogels) are suitable carriers for drug delivery and various other biomedical applications. 1-3 Hoffman, A. S. Hydrogels for biomedical applications. Advanced Drug Delivery Reviews 64, 18–23 (2012).

Temporary plugging agent for horizontal well water control, and preparation method and application thereof

The invention provides a temporary plugging agent for horizontal well water control, and a preparation method and application thereof. The temporary plugging agent for horizontal well water control comprises the following raw materials in parts by weight: 4-15 parts of acrylamide, 0.5-3 parts of polypropylene fiber, 1.5-4 parts of reinforcer, 0.5-1.0 part of composite crosslinking agent, 0.1-0.2 part of initiator and the balance of water, totaling 100 parts. The composite crosslinking agent is a mixture composed of polyethyleneglycol diacrylate and N,N-methylene-bis acrylamide in a mass ratio of 10:(1-4). The preparation method of the temporary plugging agent comprises the following steps: sequentially adding the acrylamide, polypropylene fiber, reinforcer and composite crosslinking agent into water, stirring uniformly, adding the initiator, and standing to react for 1-3 hours, thereby obtaining the temporary plugging agent. The invention also provides application of the temporary plugging agent in horizontal well water control. The temporary plugging agent provided by the invention has the characteristics of high gelling viscosity, controllable degradation time, thorough degradation and the like, can plug the high-permeability zone and implement adjustable degradation time, and can lower the damage to the reservoir.
Owner:PETROCHINA CO LTD

Anti-infection coating and preparation method thereof

The invention provides a preparation method of anti-infection coating. The preparation method comprises the following steps of (a) performing photoinitiator painting treatment on the surfaces of a medical macromolecule material to obtain a base material; (b) placing the base material obtained in the step (a) in a mixed solution comprising adhesion-resistant monomers, pH responsiveness polymerizingmonomers and polyethylene glycol diacrylate, and performing an ultraviolet cross-linking reaction to obtain a material having gel coating on the surface; and (c) performing antibiotic chemical loading on the material having gel coating on the surface obtained in the step (b) so as to obtain the anti-infection coating. According to the preparation method provided by the invention, a specific technology and a specific condition are adopted, and the anti-infection coating is obtained. The anti-infection coating has dual functions of resisting bacterium adhesion and controlling antibiotics to release for sterilization, so that bacterium adhesion can be effectively reduced, controllable release of antibiotics as required can be realized, and the problems that the bacterium-resistant effect ispoor in persistence caused by too fast antibiotic release and bacteria produce drug tolerance caused by random release of the antibiotics can be solved.
Owner:CHANGCHUN INST OF APPLIED CHEMISTRY - CHINESE ACAD OF SCI

Nano gold doped integral material for enriching glycoprotein and applications thereof

The invention relates to a preparation method of a nano gold doped integral material for enriching glycoprotein. The preparation method comprises the following steps: taking glycidyl methacrylate (GMA) and polyethylene glycol diacrylate (PEGDA) as the monomers to synthesize a hydrophilic polymer integral material substrate through an in-situ polymerization method; utilizing the epoxy groups in the substrate surface to enrich the substrate surface with mercapto groups through a chemical derivatization method, then modifying the substrate surface with nano gold particles; finally co-modifying 4-mercaptophenylboronic acid and mercaptoethylamine on the nano gold surfaces on the substrate, and enriching glycoprotein on the basis of phenylboronic acid affinity chromatography. The hydrophilicity of the monomer polyethylene glycol diacrylate (PEGDA) is utilized so as to reduce the non-specific adsorption of substrate on proteins, and thus the enrichment selectivity is improved. At the same time, the high specific surface area of nano particles is utilized at the same time, thus the enrichment capacity is increased, and finally the high-efficient and high-selective enrichment of glycoprotein is achieved.
Owner:DALIAN INST OF CHEM PHYSICS CHINESE ACAD OF SCI

Injectable temperature-sensitive magnetic nano emulsive gel and preparation method and application thereof

The invention discloses a preparation method of an injectable temperature-sensitive magnetic nano emulsive gel. The preparation method comprises the following steps: by taking a mixture of silicone oil and ZnFe2O4 nanoparticles as an oil phase and an aqueous solution where lauryl sodium sulfate is dissolved as an aqueous phase, dropwise adding the oil phase into the boiling aqueous phase while stirring to form an initial emulsion; performing uniform nanocrystallization on the initial emulsion by using an ultrasonic cell crusher to obtain a magnetic nanoemulsion; dropwise adding polyethylene glycol diacrylate (PEG-DA) into the magnetic nanoemulsion under a low temperature condition, performing uniform ultrasonic dispersion, and fully cooling the mixture to obtain the magnetic nano emulsive gel which is good in flowability at normal temperature (less than 25 DEG C) and is gelatinized at body temperature (37 DEG C). The magnetic nano emulsive gel prepared by the invention can be injected in situ in a subcutaneous tumor of a mouse under guidance of an image and is gelatinized and fixed in the part of tumor, without leaking from an injection hole or diffusing to peripheral normal tissues and blood vessels; by applying an alternating magnetic field, the ZnFe2O4 nanoparticles generate heat to cause thermal ablation of tumor tissues for necrosis and exfoliation. The method has a wide application prospect in solid tumor interventional thermotherapy.
Owner:SOUTHEAST UNIV

High-slump-retaining coagulation-retarding type polycarboxylate water reducing agent and preparation and application thereof

The invention discloses a high-slump-retaining coagulation-retarding type polycarboxylate water reducing agent and a preparation method and application thereof. The water reducing agent is prepared from, by molar part, 10-30 parts of small-molecule unsaturated carboxylic acid, 3-8 parts of ester of small-molecule unsaturated carboxylic acid, 1-5 parts of salt of small-molecule unsaturated carboxylic acid, 2-6 parts of polyethylene glycol diacrylate, 1-5 parts of an unsaturated polyether macromonomer, 8-20 parts of an acrylamide monomer, an initiator and a chain transferring agent, wherein theacrylamide monomer is a group consisting of three monomers including acrylamide (AM), 2-acrylamide-2-methylpropanesulfonic acid (AMPS) and 2-acryloylamino-2-phenylethanesulfonic acid (AMSS). The molecular structure of the water reducing agent is designed according to the construction demands for workability and slump retaining performance, and the high-slump-retaining coagulation-retarding type polycarboxylate water reducing agent with excellent comprehensive performance is finally obtained. During construction, a high water reducing rate can be achieved by applying a low dosage of the water reducing agent, the construction can be guaranteed, the slump retaining performance is excellent, the slump is basically not changed within 3 hours, and the water reducing agent has wide applicabilityin concrete construction.
Owner:深圳市五山新材料股份有限公司

Injectable bone cement and preparation method thereof

The invention relates to an injectable bone cement and preparation method thereof. The injectable bone cement comprises powder and curing liquid, wherein the powder is composited of calcium sulfate hemihydrate and polyethylene glycol diacrylate, and the curing liquid is sulfhydrylated hyaluronic acid aqueous solution or sulfhydrylated chitosan aqueous solution. The preparation method comprises the following steps of: preparing the powder of calcium sulfate hemihydrate and polyethylene glycol diacrylate inproportion; adding the curing liquid according to the liquid-to-solid ratio of 0.4-1.0mL/g, mixing and stirring evenly, and curing at room temperature to form the injectable bone cement. Sulfhydrylated hyaluronic acid and sulfhydrylated chitosan are liable to form intramolecular and intermolecular disulfide bonds under neutral condition and have higher degree of crosslinking and viscoelasticity; thus, injectable property, collapse resistance and mechanical property of the bone cement are improved. Meanwhile, the bone cement provided by the invention also has good biocompatibility and biodegradablity, and can be used for filling and repair for various bone defects. The injectable bone cement and the preparation method thereof are used in the field of tissue engineering and medicine.
Owner:TIANJIN UNIV

Ophthalmic implanted material with shape memory function and preparation method thereof

InactiveCN101785874ARegulatory mechanicsTuning shape memory propertiesProsthesisPolyethylene glycolNitrogen gas
The invention relates to an ophthalmic implanted material with the shape memory function and a preparation method thereof, belonging to the field of biomedical materials. Thermally polymerizable acrylate monomers are used as the basic material, and the mol ratio thereof is 10.0-98.0%; polyethylene glycol diacrylates or polyethylene glycol dimethyl acrylates, which have different molecular weights, are used as the cross-linking agent, and the mol ratio thereof is 2.0-90.0%; and thermal initiator accounts for 0.2-1.0% of the total mass. The thermally polymerizable monomers, the thermal initiator and the cross-linking agent are uniformly mixed under the protection of nitrogen gas, then the mixture is injected into a mold to be subject to the thermal polymerization reaction at the temperature of 70-90 DEG C for 24-48 hours, and the Soxhlet extraction is adopted to remove the unreacted monomers and oligomers to obtain the ophthalmic implanted material with the shape memory function. The invention has the advantages that the prepared material has the shape memory property, the memory property transition temperature of the material can be adjusted to the body temperature, and the material has large deformation extent and higher light transmittance in visible light areas.
Owner:UNIV OF SCI & TECH BEIJING

Production method and product of novel multiwalled carbon nanotube-dopamine-polyethyleneglycol diacrylate hydrogel film

The invention relates to a production method and a product of a novel multiwalled carbon nanotube-dopamine-polyethyleneglycol diacrylate hydrogel film. The method concretely comprises the following steps: 1, adding dopamine into a cross-linking agent solution under an anoxic condition, stirring the dopamine and the cross-linking agent solution at 45-55 DEG C in a shady place for 1-3 d, and freeze-drying the obtained solution to obtain a dopamine cross-linking agent; 2, adding a multiwalled carbon nanotube solution to the dopamine cross-linking agent, uniformly mixing the multiwalled carbon nanotube solution and the dopamine cross-linking agent, and adding polyethyleneglycol diacrylate and a photoinitiator to the obtained mixed solution to prepare a precursor solution; and 3, preparing the hydrogel from the precursor solution. The multiwalled carbon nanotube-dopamine-polyethyleneglycol diacrylate hydrogel film produced in the invention self-folds during transition from a dry environment to a water-containing environment, is independent from the concentration of the multiwalled carbon nanotube-dopamine, has the characteristics of self coiling, conductivity, cell adhesion ability and biocompatibility, affects cell differentiation, has a bone- and nerve tissue-like form after self-coiling, and has application potential in the biomedical science field.
Owner:ARMY MEDICAL UNIV

Transdermal precision drug-delivery device based on microneedle-type ionophoresis device and preparation method thereof

InactiveCN110404161AIncreased percutaneous diffusion rateEasy to adjustElectrotherapyPeptide/protein ingredientsPolyethylene glycolBlood sugar
The invention belongs to the technical field of medical drug delivery devices, and specifically discloses a transdermal precision drug-delivery device based on a microneedle-type ionophoresis device.The transdermal precision drug-delivery device comprises a composite microneedle, a DC power source and a skin electrode sheet which are sequentially connected by wires, and the composite microneedlecomprises a microneedle patch and a controllableg drug-loading substrate. The microneedle patch is a hydrogel microneedle with a grid gap formed by crosslinking polyethylene glycol-crosslinked polyvinyl methyl ether-maleic acid. The drug-loading substrate comprises a photo-cured polyethylene glycol diacrylate (PEGDA) and a composite hydrogel coated with insulin, and a back surface of the compositehydrogel is provided with a microneedle electrode sheet. The drug delivery device efficiently realizes macro-molecule transdermal administration such as insulin, and greatly improves the transdermaldiffusion rate of insulin by ion electrophoresis. The device can achieve more precise and controllable administration by changing the voltage, current and time of ion electrophoresis, realizes intelligent release and termination of insulin, and more accurately regulate blood sugar.
Owner:SUN YAT SEN UNIV

Sunscreen microcapsule taking polyethylene glycol diacrylate and preparation method thereof

The invention discloses a sunscreen microcapsule taking polyethylene glycol diacrylate as a wall material and a preparation method of the sunscreen microcapsule. The microcapsule comprises the raw materials of a core material, an initiator, an emulsifying agent, polyethylene glycol diacrylate, and deionized water. The preparation method is as follows: using the emulsifying agent and part of deionized water to prepare an emulsifying agent aqueous solution, mixing the emulsifying agent aqueous solution, polyethylene glycol diacrylate and the rest of the deionized water to obtain an aqueous phase; mixing the core material and the initiator, evenly mixing under the heating condition to obtain an oil phase; adding the aqueous phase into the oil phase, shearing, forming an emulsion; introducingnitrogen into the emulsion, mechanically stirring, reacting to obtain the microcapsule. The polyethylene glycol diacrylate macromolecule is taken as a monomer, the monomer is non-toxic, is excellent in biocompatibility, contains two double bonds, and is crosslinked under the action of the initiator to form a three-dimensional network high polymer, so that the core material is wrapped to form the sunscreen microcapsule, and the side effect caused by the direct contact between the skin and a chemical ultraviolet protecting agent is reduced.
Owner:DONGHUA UNIV

QK-polypeptide-encapsulating polylactide copolymer electrospinning fibrous membrane and preparing method

The invention relates to a QK-polypeptide-encapsulating polylactide copolymer electrospinning fibrous membrane and a preparing method. The preparing method of the polylactide copolymer electrospinning fibrous membrane includes the steps that a fibrous membrane body with the thickness of 50 micrometers to 200 micrometers is formed by polyethylene glycol-b-poly(lactide-co-epsilon-caprolactone) fibers with the diameter of 100 nm to 900 nm or poly(glycolide-co-epsilon-lactide) fibers with the diameter of 100 nm to 900 nm and chitosan gel particles encapsulated in the fibers, wherein the diameter of the chitosan gel particles is smaller than 100 nm; QK polypeptide, sulfhydrylation chitosan and polyethylene glycol 200 diacrylate are dissolved into a phosphate buffer solution to serve as a water phase (W); polylactide copolymers are dissolved into mixed solvents of chloroform and N,N-dimethylformamide to serve as an oil phase (O); the water phase is added into the oil phase, and stirring is carried out to form W / O dispersion liquid under the effect of emulsifying agents; electrospinning is carried out on the dispersing liquid to obtain the fibrous membrane. According to the QK-polypeptide-encapsulating polylactide copolymer electrospinning fibrous membrane and the preparing method, the preparing process is simple, the good biocompatibility and the good degradability are achieved, and the fibrous membrane and the preparing method can be used for the tissue engineering field and the in-situ drug sustained release field.
Owner:TIANJIN UNIV

Polylactide electrospinning composite film for in-situ gel encapsulating and preparation method thereof

The invention discloses a polylactide electrospinning composite film for in-situ gel encapsulating and a preparation method of the polylactide electrospinning composite film. The electrospinning composite film consists of poly(lactide-co-glycolide) or polyethylene glycol-b-poly(lactide-co-caprolactone) fibers and chitosan or gelatin gel particles in the fibers. The preparation method comprises the steps that: sulfydryl chitosan or sulfydryl gelatin and polyethyleneglycol diacrylate are dissolved in phosphate buffer liquid to be used as water phases; the poly(lactide-co-glycolide) or the polyethylene glycol-b-poly(lactide-co-caprolactone) is dissolved in mixed organic solvents to be used as oil phases; and the water phases are added to the oil phases, water/oil (W/O) dispersing liquid is formed through adding emulsifying agents under the stirring condition, and the electrospinning composite film is obtained through the electrospinning of the dispersing liquid. The polylactide electrospinning composite film and the preparation method have the advantages that the preparation process is simple, the prepared composite film has good biocompatibility, degradability, hydrophily and mechanical property, the medicine dumping is reduced, and the medicine release speed is adjustable and controllable. The polylactide electrospinning composite film and the preparation method are used for the tissue engineering and medicine release fields.
Owner:TIANJIN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products